Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery

Bioconjugate Chemistry

Volumn 23, Issue 5, 2012, Pages 1010-1021

  Shen, Jian Min ^a,b   Guan, Xing Mei ^a   Liu, Xiao Yan ^a   Lan, Jing Feng ^a   Cheng, Ting ^a   Zhang, Hai Xia ^a  

^a Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CADMIUM TELLURIDE; CELLS; CHITOSAN; CONTROLLED DRUG DELIVERY; CYTOLOGY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; II-VI SEMICONDUCTORS; IRON OXIDES; MOLECULAR BIOLOGY; SEMICONDUCTOR QUANTUM DOTS; TARGETED DRUG DELIVERY; TUMORS;

A549 CELLS; FOLATES; HYBRID NANOGELS; HYBRID NANOPARTICLE; LOADING EFFICIENCY; PROPERTY; SUPERPARAMAGNETIC IRON OXIDES; TERNARY HYBRID; TETRA PEPTIDE; TUMOR-TARGETED DRUG DELIVERIES;

EFFICIENCY;

CAMPTOTHECIN; CHITOSAN; COPOLYMER; FOLATE RECEPTOR; FOLIC ACID; LUMINESCENT MAGNETIC HYBRID NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOPARTICLE; PEPTIDE DERIVATIVE; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CELL VIABILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DEVICES; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DYNAMIC LIGHT SCATTERING; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; GEL; HEMOLYSIS; HUMAN; HUMAN CELL; HYBRID; INFRARED SPECTROSCOPY; INTERNALIZATION; LIGHT SCATTERING; MAGNETISM; MALE; MOUSE; NANOGEL; NONHUMAN; PARTICLE SIZE; PH; ROENTGEN SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR TARGETED DRUG DELIVERY; VIBRATING SAMPLE MAGNETOMETER; X RAY DIFFRACTION; X RAY ENERGY DISPERSIVE SPECTROSCOPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CADMIUM COMPOUNDS; CAMPTOTHECIN; CELL LINE, TUMOR; CHITOSAN; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; LUMINESCENCE; LUMINESCENT AGENTS; MAGNETITE NANOPARTICLES; MICELLES; NEOPLASMS; OLIGOPEPTIDES; QUANTUM DOTS; TELLURIUM;

EID: 84861147200     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300008k     Document Type: Article

References (36)

1. Galbiati, A., Tabolacci, C., Rocca, B. M. D., Mattioli, P., Beninati, S., Paradossi, G., and Desideri, A. (2011) Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin Bioconjugate Chem. 22, 1066-1072
2. Bandyopadhyay, K. and Gjerset, R. A. (2011) Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines Biochemistry 50, 704-714
3. Mi, Z. H. and Burke, T. G. (1994) Marked interspecies variations concerning the interactions of camptothecin with serum albumins: A frequency-domain fluorescence spectroscopic study Biochemistry 33, 12540-12545
4. Burke, T. G., Staubus, A. E., and Mishra, A. K. (1992) Liposomal stabilization of camptotbecin's lactone ring J. Am. Chem. Soc. 114, 8318-8319
5. Mi, Z. H. and Burke, T, G. (1994) Differential interactions of camptothecin lactone and carboxylate forms with human blood components Biochemistry 33, 10325-10336
6. Thambi, T., Yoon, H. Y., Kim, K., Kwon, I. C., Yoo, C. K., and Park, J. H. (2011) Bioreducible block copolymers based on poly(ethylene glycol) and poly(γ-benzyl L-glutamate) for intracellular delivery of camptothecin Bioconjugate Chem. 22, 1924-1931
7. Zhang, K., Wang, Y. J., Yu, A., Zhang, Y., Tang, H., and Zhu, X. X. (2010) Cholic acid-modified dendritic multimolecular micelles and enhancement of anticancer drug therapeutic efficacy Bioconjugate Chem. 21, 1596-1601
8. Meenach, S. A., Kim, Y. J., Kauffman, K. J., Kanthamneni, N., Bachelder, E. M., and Ainslie, K. M. (2011) Synthesis, optimization and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery. Mol. Pharmaceutics DOI: 10.1021/mp2003785.
9. Machida, Y., Onishi, H., Kurita, A., Hata, H., and Morikawa, A. (2000) Pharmacokinetics of prolonged-release CPT-11-loaded micro-spheres in rats J. Controlled Release 66, 159-175
10. Musumeci, T., Ventura, C. A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., and Puglisi, G. (2006) PLA/PLGA nanoparticles for sustained release of docetaxel Int. J. Pharm. 325, 172-179
11. Guo, J., Yang, W. L., Wang, C. C., He, J., and Chen, J. Y. (2006) Poly(N-isopropylacrylamide)-coated luminescent/magnetic silica microspheres: Preparation, characterization, and biomedical applications Chem. Mater. 18, 5554-5562
12. Chen, J. P., Yang, P. C., Ma, Y. H., and Wu, T. (2011) Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator Carbohydr. Polym. 84, 364-372
13. Kong, S. D., Zhang, W. Z., Lee, J. H., Brammer, K., Lal, R., Karin, M., and Jin, S. (2010) Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release Nano Lett. 10, 5088-5092
14. Mathew, M. E., Mohan, J. C., Manzoor, K., Nair, S. V., Tamura, H., and Jayakumar, R. (2010) Folate conjugated carboxymethyl chitosan-manganese doped zinc sulphide nanoparticles for targeted drug delivery and imaging of cancer cells Carbohydr. Polym. 80, 442-448
15. Mangeney, C., Bousalem, S., Connan, C., Vaulay, M., Bernard, S., and Chehimi, M. M. (2006) Latex and hollow particles of reactive polypyrrole: Preparation, properties, and decoration by gold nanospheres Langmuir 22, 10163-10169
16. Cho, H. S., Dong, Z. Y., Pauletti, G. M., Zhang, J. M., Xu, H., Gu, H. C., Wang, L. M., Ewing, R. C., Huth, C., Wang, F., and Shi, D. L. (2010) Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: A multifunctional nanocarrier system for cancer diagnosis and treatment Nano 4, 5398-5404
17. Shen, J. M., Xu, L., Lu, Y., Cao, H. M., Xu, Z. G., Chen, T., and Zhang, H. X. (2012) Chitosan-based luminescent/magnetic hybrid nanogels for insulin delivery, cell imaging, and antidiabetic research of dietary supplements. Int. J. Pharm. 2012, 427 (2): 400-409.
18. Jayakumar, R., Menon, D., Manzoor, K., Nair, S. V., and Tamura, H. (2010) Biomedical applications of chitin and chitosan based nanomaterials-A short review Carbohydr. Polym. 82, 227-232
19. Corato, R. D., Bigall, N. C., Ragusa, A., Dorfs, D., Genovese, A., Marotta, R., Manna, L., and Pellegrino, T. (2011) Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: Synthesis and cancer cell targeting and sorting Nano 5, 1109-1121
20. Xia, W. S., Liu, P., Zhang, J. L., and Chen, J. (2011) Biological activities of chitosan and chitooligosaccharides Food Hydrocolloid 25, 170-179
21. Suzuki, K., Mikami, T., Okawa, Y., Tokoro, A., Suzuki, S., and Suzuki, M. (1986) Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose Carbohydr. Res. 151, 403-408
22. Yang, S. J., Lin, F. H., Tsai, K. C., Wei, M. F., Tsai, H. M., Wong, J. M., and Shieh, M. J. (2010) Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells Bioconjugate Chem. 21, 679-689
23. Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., and Gong, S. Q. (2009) Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery Biomaterials 30, 3009-3019
24. Mahato, R., Tai, W. Y., and Cheng, K. (2011) Prodrugs for improving tumor targetability and efficiency Adv. Drug Delivery Rev. 63, 659-670
25. Shi, Z. L., Neoh, K. G., Kang, E. T., Shuter, B., Wang, S. C., Poh, C., and Wang, W. (2009) (Carboxymethyl)chitosan-modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of stem cells ACS Appl. Mater. Interfaces 1, 328-335
26. Wu, W. T., Shen, J., Banerjee, P., and Zhou, S. Q. (2010) Chitosan-based responsive hybrid nanogels for integration of optical pH-sensing, tumor cell imaging and controlled drug delivery Biomaterials 31, 8371-8381
27. Moody, T. W., Mantey, S. A., Fuselier, J. A., Coy, D. H., and Jensen, R. T. (2007) Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells Peptides 28, 1883-1890
28. Pozzo, A. D., Ni, M. H., Esposito, E., Dallavalle, S., Musso, L., Bargiotti, A., Pisano, C., Vesci, L., Bucci, F., Castorina, M., Foderà, R., Giannini, G., Aulicino, C., and Penco, S. (2010) Novel tumor-targeted RGD peptide-camptothecin conjugates: Synthesis and biological evaluation Bioorg. Med. Chem. 18, 64-72
29. Aluri, S., Janib, S. M., and Mackay, J. A. (2009) Environmentally responsive peptides as anticancer drug carriers Adv. Drug Delivery Rev. 61, 940-952
30. Zhang, X. X., Eden, H. S., and Chen, X. Y. (2011) Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates J. Controlled Release 10.1016/j.jconrel.2011.10.023
31. Henne, W. A., Doorneweerd, D. D., Hilgenbrink, A. R., Kularatne, S. A., and Low, P. S. (2006) Synthesis and activity of a folate peptide camptothecin prodrug Bioorg. Med. Chem. Lett. 16, 5350-5355
32. Wu, H. X., Zhang, S. J., Zhang, J. M., Liu, G., Shi, J. L., Zhang, L. X., Cui, X. Z., Ruan, M. L., He, Q. J., and Bu, W. B. (2011) A hollow-core, magnetic, and mesoporous double-shell nanostructure: In situ decomposition/reduction synthesis, bioimaging, and drug-delivery properties Adv. Funct. Mater. 21, 1850-1862
33. Sun, Y. N., Wang, C. D., Zhang, X. M., Ren, L., and Tian, X. H. (2011) Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution J. Nanosci. Nanotechnol. 11, 1210-1216
34. Lin, Y. S. and Haynes, C. L. (2010) Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity J. Am. Chem. Soc. 132, 4834-4842
35. Miyakem, M., Honda, T., and Miwatani, T. (1989) Effect of divalent cations and saccharides on Vibrio metschnikovii cytolysin-induced hemolysis of rabbit erythrocytes Infect. Immun. 57, 158-163
36. Yoo, H. S. and Park, T. G. (2004) Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate J. Controlled Release 100, 247-256